Pulmonary hypertension causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(27 intermediate revisions by 11 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pulmonary hypertension}}
{{Pulmonary hypertension}}
{{CMG}}; {{AE}} [[User:Ralph Matar|Ralph Matar]]; {{MM}}
{{CMG}}; {{AE}} [[User:Ralph Matar|Ralph Matar]]; {{MM}}; {{Jose}}


==Overview==
==Overview==
Pulmonary hypertension can be classified into primary pulmonary hypertension (of unknown cause) which is currently known as idiopathic pulmonary arterial hypertension (IPAH) and secondary pulmonary hypertension due to another medical condition.  The most common cause of pulmonary hypertension is [[left heart failure]].  Other common causes include [[HIV]], [[systemic sclerosis]], [[portal hypertension]], [[congenital heart disease]] and [[sickle cell disease]].<ref name="pmid14985486">{{cite journal| author=Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al.| title=Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 9 | pages= 886-95 | pmid=14985486 | doi=10.1056/NEJMoa035477 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14985486 }} </ref>
[[Pulmonary hypertension]] may be caused by either [[left heart failure]] (the most common cause) or other somewhat common causes such as [[HIV]], [[systemic sclerosis]], [[portal hypertension]], [[congenital heart disease]], and [[sickle cell disease]].
The World Health Organization (WHO) has classified PH based on etiology into five distinct groups: Group 1 (pulmonary arterial hypertension), Group 2 ([[PH]] due to [[left heart failure]]), Group 3 ([[PH]] due to [[chronic lung disease]] and/or [[hypoxemia]]), Group 4 ([[PH]] due to [[chronic thromboembolic disease]]), and Group 5 ([[PH]] due to multifactorial mechanisms).


==Causes==
==Causes==


===Life Threatening Causes===
===Life Threatening Causes===
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary hypertension in itself is not a life threatening condition, but it is progressively fatal if left untreated. [[Pulmonary embolism]] and acute [[left heart failure]] are two causes of pulmonary hypertension that can be quickly fatal.
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.  
*Pulmonary hypertension itself is not a life-threatening condition, but it is progressively fatal if left untreated. [[Pulmonary embolism|Pulmonary embolism]] and [[left heart failure|acute left heart failure]] are two causes of pulmonary hypertension that can be quickly fatal.


===Common Causes===
===Common Causes===
The most common cause of pulmonary hypertension is [[left heart failure]] leading to pulmonary venous hypertension. Other Common causes of pulmonary arterial hypertension (PAH) include:
The most common cause of pulmonary hypertension is [[left heart failure]] leading to pulmonary venous hypertension. Other common causes of pulmonary arterial hypertension (PAH) include:<ref name="pmid14985486">{{cite journal| author=Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al.| title=Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 9 | pages= 886-95 | pmid=14985486 | doi=10.1056/NEJMoa035477 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14985486 }} </ref><ref name="pmid23852284">{{cite journal| author=Nayak NC, Chitale AR| title=Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions. | journal=Indian J Med Res | year= 2013 | volume= 137 | issue= 6 | pages= 1029-42 | pmid=23852284 | doi= | pmc=PMC3734708 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23852284 }} </ref><ref name="pmid9776954">{{cite journal| author=Schultze AE, Roth RA| title=Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. | journal=J Toxicol Environ Health B Crit Rev | year= 1998 | volume= 1 | issue= 4 | pages= 271-346 | pmid=9776954 | doi=10.1080/10937409809524557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9776954 }} </ref><ref name="pmid23741096">{{cite journal| author=Kashyap S, Mohapatra PR| title=Pulmonary alveolar microlithiasis. | journal=Lung India | year= 2013 | volume= 30 | issue= 2 | pages= 143-7 | pmid=23741096 | doi=10.4103/0970-2113.110424 | pmc=PMC3669555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23741096 }} </ref>
 
*[[Cor pulmonale]] ([[right heart failure]] due to [[pulmonary disease]])
*[[Cor pulmonale]] ([[Right heart failure]] due to [[pulmonary disease]])
*[[Congestive heart failure]]
*[[Congestive heart failure]]
*[[Congenital heart disease]]
*[[Congenital heart disease]]
*[[Chronic pulmonary thromboembolism]]
*[[COPD]]
*[[COPD]]
*[[Pulmonary Hypertension|Familial Pulmonary Hypertension]]
*[[Pulmonary Hypertension|Familial Pulmonary Hypertension]]
Line 25: Line 27:
*[[Portal hypertension]]
*[[Portal hypertension]]
*[[Pickwickian syndrome]]
*[[Pickwickian syndrome]]
*[[Diseases of the valvular structures|Right sided valvular disease]]
*[[Diseases of the valvular structures|Right-sided valvular disease]]
*[[Systemic sclerosis]]
*[[Systemic sclerosis]]
*[[Sickle cell disease]]<ref name="pmid14985486">{{cite journal| author=Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K et al.| title=Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 9 | pages= 886-95 | pmid=14985486 | doi=10.1056/NEJMoa035477 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14985486 }} </ref>
*[[Systemic lupus erythematosus]]
*[[Sickle cell disease]]
*[[Stimulant drugs]] such as amphetamines


====Idiopathic Pulmonary Arterial Hypertension====
====Idiopathic Pulmonary Arterial Hypertension====
Line 34: Line 38:
=== Causes by Organ System ===
=== Causes by Organ System ===


{|style="width:70%; height:100px" border="1"
{| style="width:70%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
| style="width:25%" bgcolor="LightSteelBlue" ; border="1" | '''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[ASD|Atrial septal defect]], [[cor triatriatum]], [[left heart failure]], [[Fallot tetralogy]], [[persistent fetal circulation]], [[mitral valve stenosis]], [[mitral valve insufficiency]], [[ventricular septal defect]]   
| style="width:75%" bgcolor="Beige" ; border="1" | [[ASD|Atrial septal defect]], [[cor triatriatum]], [[left heart failure]], [[Fallot tetralogy]], [[persistent fetal circulation]], [[mitral valve stenosis]], [[mitral valve insufficiency]], [[ventricular septal defect]]   
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Chemical / poisoning'''
| '''Chemical / poisoning'''
|bgcolor="Beige"| [[Coal workers' pneumoconiosis]]
| bgcolor="Beige" | [[Coal workers' pneumoconiosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Dermatologic'''
| '''Dermatologic'''
|bgcolor="Beige"| [[Neurofibromatosis]], [[systemic lupus erythematosus]]
| bgcolor="Beige" | [[Neurofibromatosis]], [[systemic lupus erythematosus]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Drug and Toxin Side Effect'''
| '''Drug and Toxin Side Effect'''
|bgcolor="Beige"|  Definite: [[Aminorex]], [[benfluorex]], [[dexfenfluramine]], [[fenfluramine]], toxic [[rapeseed]] oil, [[benfluorex]], <br> Likely: [[Amphetamines]], L-[[tryptophan]], [[methamphetamine]] <br> Possible: [[Cocaine]], [[phenylpropanolamine]], [[pergolide]], [[St John's wort]], [[chemotherapeutic agents]], [[SSRI]]
| bgcolor="Beige" |  Definite: [[Aminorex]], [[Carfilzomib]], [[benfluorex]], [[dexfenfluramine]], [[Diethylpropion]], [[fenfluramine]], toxic [[rapeseed]] oil, [[benfluorex]], <br> Likely: [[Amphetamines]], L-[[tryptophan]], [[methamphetamine]] <br> Possible: [[Cocaine]], [[Lorcaserin]], [[Pegylated interferon alfa-2b]], [[phentermine]], [[phenylpropanolamine]], [[pergolide]],[[Protamine sulfate]],[[St John's wort]], [[chemotherapeutic agents]], [[SSRI]], [[Aprotinin]]


|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Ear Nose Throat'''
| '''Ear Nose Throat'''
|bgcolor="Beige"| [[Pickwickian syndrome]]
| bgcolor="Beige" | [[Pickwickian syndrome]]
|-  
|-  
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Endocrine'''
| '''Endocrine'''
|bgcolor="Beige"| [[Thyroid diseases]]
| bgcolor="Beige" | [[Thyroid diseases]]
|-  
|-  
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Environmental'''
| '''Environmental'''
|bgcolor="Beige"| [[High altitude sickness|High Altitude (chronically)]]
| bgcolor="Beige" | [[High altitude sickness|High Altitude (chronically)]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| [[Portal hypertension]]
| bgcolor="Beige" | [[Portal hypertension]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cholesterol ester storage disease]], [[cystic fibrosis]], [[Gaucher disease]], Indian familial childhood cirrhosis<ref name="pmid23852284">{{cite journal| author=Nayak NC, Chitale AR| title=Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions. | journal=Indian J Med Res | year= 2013 | volume= 137 | issue= 6 | pages= 1029-42 | pmid=23852284 | doi= | pmc=PMC3734708 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23852284 }} </ref>
| bgcolor="Beige" | [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cholesterol ester storage disease]], [[cystic fibrosis]], [[Gaucher disease]], Indian familial childhood cirrhosis
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Hematologic'''
| '''Hematologic'''
|bgcolor="Beige"| [[Myeloproliferative disorders]], [[paroxysmal nocturnal haemoglobinuria]], [[polycythemia vera]], [[splenectomy]], [[sickle cell disease]]
| bgcolor="Beige" | [[Myeloproliferative disorders]], [[paroxysmal nocturnal haemoglobinuria]], [[polycythemia vera]], [[splenectomy]], [[sickle cell disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Iatrogenic'''
| '''Iatrogenic'''
|bgcolor="Beige"| No underlying cause
| bgcolor="Beige" | No underlying cause
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Infectious Disease'''
| '''Infectious Disease'''
|bgcolor="Beige"| [[ Kaposi's sarcoma-associated herpesvirus|HHV-8]], [[schistosoma japonicum]] and [[schistosoma mansoni]]
| bgcolor="Beige" | [[ Kaposi's sarcoma-associated herpesvirus|HHV-8]], [[schistosoma japonicum]] and [[schistosoma mansoni]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Musculoskeletal / Ortho'''
| '''Musculoskeletal / Ortho'''
|bgcolor="Beige"| [[Scoliosis|Idiopathic spinal scoliosis]]
| bgcolor="Beige" | [[Scoliosis|Idiopathic spinal scoliosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Neurologic'''
| '''Neurologic'''
|bgcolor="Beige"| No underlying cause
| bgcolor="Beige" | No underlying cause
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Nutritional / Metabolic'''
| '''Nutritional / Metabolic'''
|bgcolor="Beige"| No underlying cause
| bgcolor="Beige" | No underlying cause
   
   
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| No underlying cause
| bgcolor="Beige" | No underlying cause


|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Oncologic'''
| '''Oncologic'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Opthalmologic'''
| '''Opthalmologic'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Overdose / Toxicity'''
| '''Overdose / Toxicity'''
|bgcolor="Beige"| [[Diethylpropion]], monocrotaline,<ref name="pmid9776954">{{cite journal| author=Schultze AE, Roth RA| title=Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. | journal=J Toxicol Environ Health B Crit Rev | year= 1998 | volume= 1 | issue= 4 | pages= 271-346 | pmid=9776954 | doi=10.1080/10937409809524557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9776954 }} </ref> [[phentermine]], [[radiation exposure]] (fibrosing [[mediastinitis]] and [[pulmonary fibrosis]]).
| bgcolor="Beige" | [[Diethylpropion]], monocrotaline, [[phentermine]], [[radiation exposure]] (fibrosing [[mediastinitis]] and [[pulmonary fibrosis]]).
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Psychiatric'''
| '''Psychiatric'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Pulmonary'''
| '''Pulmonary'''
|bgcolor="Beige"| [[Idiopathic pulmonary hemosiderosis]], [[sarcoidosis]], [[primary pulmonary hypertension]], [[pulmonary fibrosis]], [[alveolar capillary dysplasia|alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cystic fibrosis]], [[pulmonary embolism]], [[tropical pulmonary eosinophilia]], [[pulmonary capillary hemangiomatosis]], [[bronchiectasis]],[[bronchopulmonary dysplasia]], [[chronic obstructive pulmonary disease]], pulmonary alveolar microlithiasis,<ref name="pmid23741096">{{cite journal| author=Kashyap S, Mohapatra PR| title=Pulmonary alveolar microlithiasis. | journal=Lung India | year= 2013 | volume= 30 | issue= 2 | pages= 143-7 | pmid=23741096 | doi=10.4103/0970-2113.110424 | pmc=PMC3669555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23741096 }} </ref> [[pulmonary fibrosis]], [[Langerhans cell histiocytosis]],[[interstitial lung disease]].
| bgcolor="Beige" | [[Idiopathic pulmonary hemosiderosis]], [[sarcoidosis]], [[primary pulmonary hypertension]], [[pulmonary fibrosis]], [[alveolar capillary dysplasia|alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cystic fibrosis]], [[pulmonary embolism]], [[tropical pulmonary eosinophilia]], [[pulmonary capillary hemangiomatosis]], [[bronchiectasis]],[[bronchopulmonary dysplasia]], [[chronic obstructive pulmonary disease]], pulmonary alveolar microlithiasis, [[pulmonary fibrosis]], [[Langerhans cell histiocytosis]],[[interstitial lung disease]].
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Renal / Electrolyte'''
| '''Renal / Electrolyte'''
|bgcolor="Beige"| [[renal failure|Chronic renal failure]] on [[dialysis]]
| bgcolor="Beige" | [[renal failure|Chronic renal failure]] on [[dialysis]]
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Rheum / Immune / Allergy'''
| '''Rheum / Immune / Allergy'''
|bgcolor="Beige"|  [[Vasculitis]], [[Churg-Strauss syndrome]], [[sarcoidosis]], [[systemic sclerosis]], [[systemic lupus erythematosus]].
| bgcolor="Beige" |  [[Vasculitis]], [[Churg-Strauss syndrome]], [[sarcoidosis]], [[systemic sclerosis]], [[systemic lupus erythematosus]].
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Sexual'''
| '''Sexual'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Trauma'''
| '''Trauma'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Urologic'''
| '''Urologic'''
|bgcolor="Beige"| No underlying causes
| bgcolor="Beige" | No underlying causes
|-
|-
|-bgcolor="LightSteelBlue"
|- bgcolor="LightSteelBlue"
| '''Miscellaneous'''
| '''Miscellaneous'''
|bgcolor="Beige"| [[Gaucher disease]], [[glycogen storage diseases]], [[scoliosis|idiopathic spinal scoliosis]],   
| bgcolor="Beige" | [[Gaucher disease]], [[glycogen storage diseases]], [[scoliosis|idiopathic spinal scoliosis]],   
|-
|-
|}
|}


=== Causes in Alphabetical Order ===
=== Causes in Alphabetical Order ===
 
{{columns-list|
{{MultiCol|width: 80%}}
* [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]]
* [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]]
* [[Atrial Septal Defects]]
* [[Atrial Septal Defects]]
Line 171: Line 174:
* [[High altitude sickness|High Altitude(chronically)]]
* [[High altitude sickness|High Altitude(chronically)]]
* [[Idiopathic pulmonary haemosiderosis]]
* [[Idiopathic pulmonary haemosiderosis]]
* Indian familial childhood cirrhosis<ref name="pmid23852284">{{cite journal| author=Nayak NC, Chitale AR| title=Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions. | journal=Indian J Med Res | year= 2013 | volume= 137 | issue= 6 | pages= 1029-42 | pmid=23852284 | doi= | pmc=PMC3734708 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23852284 }} </ref>
* Indian familial childhood cirrhosis
* [[Interstitial Lung Disease]]
* [[Interstitial Lung Disease]]
* [[Scoliosis|Idiopathic spinal scoliosis]]
* [[Scoliosis|Idiopathic spinal scoliosis]]
* [[Langerhans cell histiocytosis]]
* [[Langerhans cell histiocytosis]]
* [[Mitral valve insufficiency]]
* [[Mitral valve insufficiency]]
{{ColBreak}}
* [[Mitral valve stenosis]]
* [[Mitral valve stenosis]]
* Monocrotaline poisoning<ref name="pmid9776954">{{cite journal| author=Schultze AE, Roth RA| title=Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. | journal=J Toxicol Environ Health B Crit Rev | year= 1998 | volume= 1 | issue= 4 | pages= 271-346 | pmid=9776954 | doi=10.1080/10937409809524557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9776954 }} </ref>
* Monocrotaline poisoning
* [[Myeloproliferative disorders]]
* [[Myeloproliferative disorders]]
* [[Neurofibromatosis]]
* [[Neurofibromatosis]]
* [[Obstructive sleep apnea]]
* [[Obstructive sleep apnea]]
* [[Paroxysmal nocturnal haemoglobinuria]]
* [[Paroxysmal nocturnal haemoglobinuria]]
*[[Pergolide]]
* [[Phentermine|Phentermine poisoning]]
* [[Phentermine|Phentermine poisoning]]
* [[Pickwickian syndrome]]
* [[Pickwickian syndrome]]
* [[Portal hypertension]]
* [[Portal hypertension]]
* [[Polycythemia vera]]
* [[Polycythemia vera]]
* Pulmonary alveolar microlithiasis<ref name="pmid23741096">{{cite journal| author=Kashyap S, Mohapatra PR| title=Pulmonary alveolar microlithiasis. | journal=Lung India | year= 2013 | volume= 30 | issue= 2 | pages= 143-7 | pmid=23741096 | doi=10.4103/0970-2113.110424 | pmc=PMC3669555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23741096 }} </ref>
* Pulmonary alveolar microlithiasis
* [[Pulmonary capillary hemangiomatosis]]
* [[Pulmonary capillary hemangiomatosis]]
* [[Pulmonary embolism]]
* [[Pulmonary embolism]]
Line 202: Line 205:
* [[Vasculitis]]
* [[Vasculitis]]
* [[Ventricular septal defect]]
* [[Ventricular septal defect]]
{{EndMultiCol}}
}}


=== Causes by Clinical Classification ===
=== Causes by Clinical Classification ===
Line 208: Line 211:
<u>'''Class 1:'''</u> Pulmonary arterial hypertension
<u>'''Class 1:'''</u> Pulmonary arterial hypertension
# [[Pulmonary hypertension|Idiopathic pulmonary arterial hypertension]]
# [[Pulmonary hypertension|Idiopathic pulmonary arterial hypertension]]
# Heritable (BMPR2, ALK-1, ENG, SMAD9, CAV1, KCNK3, etc.)
# Heritable ([[BMPR2]], [[ALK-1]], [[ENG]], [[SMAD9]], [[CAV1]], [[KCNK3]])
# Drug and toxin induced
# Drug and toxin induced
:* [[Aminorex]]
:* [[Fenfluramine]]
:* [[Dexfenfluramine]]
:* Toxic [[rapeseed oil]]
:* [[Benfluorex]]
:* [[SSRI]]s


<u>'''Class 2:'''</u> Pulmonary hypertension due to left heart disease
<u>'''Class 2:'''</u> Pulmonary hypertension due to left heart disease
Line 229: Line 238:


<u>'''Class 5:'''</u> Pulmonary hypertension with unclear multifactorial mechanisms
<u>'''Class 5:'''</u> Pulmonary hypertension with unclear multifactorial mechanisms
#'''Hematologic disorders''': chronic [[hemolytic anemia]], [[Myeloproliferative disorders]], [[splenectomy]],
#'''Hematologic disorders''': Chronic [[hemolytic anemia]], [[Myeloproliferative disorders]], [[splenectomy]],
#'''Systemic disorders''': [[sarcoidosis]], [[Langerhans cell histiocytosis|pulmonary histiocytosis]], [[lymphangioleiomyomatosis]]
#'''Systemic disorders''': [[Sarcoidosis]], [[Langerhans cell histiocytosis|pulmonary histiocytosis]], [[lymphangioleiomyomatosis]]
#'''Metabolic disorders''': [[glycogen storage disease]], [[Gaucher disease]], thyroid disorders
#'''Metabolic disorders''': [[Glycogen storage disease]], [[Gaucher disease]], [[thyroid disorders]]
#'''Miscellaneous''': tumoral obstruction, fibrosing [[mediastinitis]], [[chronic renal failure]], segmental PH
#'''Miscellaneous''': Tumoral obstruction, fibrosing [[mediastinitis]], [[chronic renal failure]], segmental PH


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
 
{{WikiDoc Sources}}
[[Category:Medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Mature chapter]]
[[Category:Signs and symptoms]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 13:29, 9 June 2021

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension causes

CDC on Pulmonary hypertension causes

Pulmonary hypertension causes in the news

Blogs on Pulmonary hypertension causes

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ralph Matar; Mohamed Moubarak, M.D. [2]; José Eduardo Riceto Loyola Junior, M.D.[3]

Overview

Pulmonary hypertension may be caused by either left heart failure (the most common cause) or other somewhat common causes such as HIV, systemic sclerosis, portal hypertension, congenital heart disease, and sickle cell disease. The World Health Organization (WHO) has classified PH based on etiology into five distinct groups: Group 1 (pulmonary arterial hypertension), Group 2 (PH due to left heart failure), Group 3 (PH due to chronic lung disease and/or hypoxemia), Group 4 (PH due to chronic thromboembolic disease), and Group 5 (PH due to multifactorial mechanisms).

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

  • Pulmonary hypertension itself is not a life-threatening condition, but it is progressively fatal if left untreated. Pulmonary embolism and acute left heart failure are two causes of pulmonary hypertension that can be quickly fatal.

Common Causes

The most common cause of pulmonary hypertension is left heart failure leading to pulmonary venous hypertension. Other common causes of pulmonary arterial hypertension (PAH) include:[1][2][3][4]

Idiopathic Pulmonary Arterial Hypertension

When none of the causes on this page can be found, the disease is termed idiopathic pulmonary arterial hypertension (IPAH).

Causes by Organ System

Cardiovascular Atrial septal defect, cor triatriatum, left heart failure, Fallot tetralogy, persistent fetal circulation, mitral valve stenosis, mitral valve insufficiency, ventricular septal defect
Chemical / poisoning Coal workers' pneumoconiosis
Dermatologic Neurofibromatosis, systemic lupus erythematosus
Drug and Toxin Side Effect Definite: Aminorex, Carfilzomib, benfluorex, dexfenfluramine, Diethylpropion, fenfluramine, toxic rapeseed oil, benfluorex,
Likely: Amphetamines, L-tryptophan, methamphetamine
Possible: Cocaine, Lorcaserin, Pegylated interferon alfa-2b, phentermine, phenylpropanolamine, pergolide,Protamine sulfate,St John's wort, chemotherapeutic agents, SSRI, Aprotinin
Ear Nose Throat Pickwickian syndrome
Endocrine Thyroid diseases
Environmental High Altitude (chronically)
Gastroenterologic Portal hypertension
Genetic Alveolar capillary dysplasia with misalignment of pulmonary veins, cholesterol ester storage disease, cystic fibrosis, Gaucher disease, Indian familial childhood cirrhosis
Hematologic Myeloproliferative disorders, paroxysmal nocturnal haemoglobinuria, polycythemia vera, splenectomy, sickle cell disease
Iatrogenic No underlying cause
Infectious Disease HHV-8, schistosoma japonicum and schistosoma mansoni
Musculoskeletal / Ortho Idiopathic spinal scoliosis
Neurologic No underlying cause
Nutritional / Metabolic No underlying cause
Obstetric/Gynecologic No underlying cause
Oncologic No underlying causes
Opthalmologic No underlying causes
Overdose / Toxicity Diethylpropion, monocrotaline, phentermine, radiation exposure (fibrosing mediastinitis and pulmonary fibrosis).
Psychiatric No underlying causes
Pulmonary Idiopathic pulmonary hemosiderosis, sarcoidosis, primary pulmonary hypertension, pulmonary fibrosis, alveolar capillary dysplasia with misalignment of pulmonary veins, cystic fibrosis, pulmonary embolism, tropical pulmonary eosinophilia, pulmonary capillary hemangiomatosis, bronchiectasis,bronchopulmonary dysplasia, chronic obstructive pulmonary disease, pulmonary alveolar microlithiasis, pulmonary fibrosis, Langerhans cell histiocytosis,interstitial lung disease.
Renal / Electrolyte Chronic renal failure on dialysis
Rheum / Immune / Allergy Vasculitis, Churg-Strauss syndrome, sarcoidosis, systemic sclerosis, systemic lupus erythematosus.
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Gaucher disease, glycogen storage diseases, idiopathic spinal scoliosis,

Causes in Alphabetical Order

Causes by Clinical Classification

Class 1: Pulmonary arterial hypertension

  1. Idiopathic pulmonary arterial hypertension
  2. Heritable (BMPR2, ALK-1, ENG, SMAD9, CAV1, KCNK3)
  3. Drug and toxin induced

Class 2: Pulmonary hypertension due to left heart disease

  1. Left ventricular systolic dysfunction
  2. Left ventricular diastolic dysfunction
  3. Valvular disease
  4. Congenital/acquired left heart inflow/outflow tract obstruction and congenital cardiomyopathies

Class 3: Pulmonary hypertension due to lung diseases and/or hypoxia

  1. Chronic obstructive pulmonary disease
  2. Interstitial lung disease
  3. Other pulmonary diseases with mixed restrictive and obstructive pattern
  4. Sleep-disordered breathing
  5. Alveolar hypoventilation disorders
  6. Chronic exposure to high altitude
  7. Developmental lung diseases

Class 4: Chronic thromboembolic pulmonary hypertension

Class 5: Pulmonary hypertension with unclear multifactorial mechanisms

  1. Hematologic disorders: Chronic hemolytic anemia, Myeloproliferative disorders, splenectomy,
  2. Systemic disorders: Sarcoidosis, pulmonary histiocytosis, lymphangioleiomyomatosis
  3. Metabolic disorders: Glycogen storage disease, Gaucher disease, thyroid disorders
  4. Miscellaneous: Tumoral obstruction, fibrosing mediastinitis, chronic renal failure, segmental PH

References

  1. ↑ Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K; et al. (2004). "Pulmonary hypertension as a risk factor for death in patients with sickle cell disease". N Engl J Med. 350 (9): 886–95. doi:10.1056/NEJMoa035477. PMID 14985486.
  2. ↑ Nayak NC, Chitale AR (2013). "Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions". Indian J Med Res. 137 (6): 1029–42. PMC 3734708. PMID 23852284.
  3. ↑ Schultze AE, Roth RA (1998). "Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system". J Toxicol Environ Health B Crit Rev. 1 (4): 271–346. doi:10.1080/10937409809524557. PMID 9776954.
  4. ↑ Kashyap S, Mohapatra PR (2013). "Pulmonary alveolar microlithiasis". Lung India. 30 (2): 143–7. doi:10.4103/0970-2113.110424. PMC 3669555. PMID 23741096.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Pulmonary_hypertension_causes&oldid=1703575"